Genetic Analysis AS 8V8.F Stock
Genetic Analysis AS Price Chart
Genetic Analysis AS 8V8.F Financial and Trading Overview
| Genetic Analysis AS stock price | 0.04 EUR |
| Previous Close | 0.13 EUR |
| Open | 0.12 EUR |
| Bid | 0.12 EUR x N/A |
| Ask | 0.15 EUR x N/A |
| Day's Range | 0.12 - 0.12 EUR |
| 52 Week Range | 0.09 - 0.28 EUR |
| Volume | 1 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 3.49M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
8V8.F Valuation Measures
| Enterprise Value | -7153505 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.15660778 |
| Price/Book (mrq) | 0.08395144 |
| Enterprise Value/Revenue | -0.321 |
| Enterprise Value/EBITDA | 0.261 |
Trading Information
Genetic Analysis AS Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -45.32% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.28 EUR |
| 52 Week Low | 0.09 EUR |
| 50-Day Moving Average | 0.12 EUR |
| 200-Day Moving Average | 0.15 EUR |
8V8.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 24.92M |
| Float | 11.59M |
| Short Ratio | N/A |
| % Held by Insiders | 78.20% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -125.17% |
| Operating Margin (ttm) | -124.64% |
| Gross Margin | 85.65% |
| EBITDA Margin | -123.033% |
Management Effectiveness
| Return on Assets (ttm) | -26.70% |
| Return on Equity (ttm) | -54.96% |
Income Statement
| Revenue (ttm) | 22.28M EUR |
| Revenue Per Share (ttm) | 0.89 EUR |
| Quarterly Revenue Growth (yoy) | 31.69% |
| Gross Profit (ttm) | 16.84M EUR |
| EBITDA | -27408420 EUR |
| Net Income Avi to Common (ttm) | -27886040 EUR |
| Diluted EPS (ttm) | -0.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.3M EUR |
| Total Cash Per Share (mrq) | 0.69 EUR |
| Total Debt (mrq) | 6.87M EUR |
| Total Debt/Equity (mrq) | 18.59 EUR |
| Current Ratio (mrq) | 2.451 |
| Book Value Per Share (mrq) | 1.483 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20619620 EUR |
| Levered Free Cash Flow (ttm) | -10242468 EUR |
Profile of Genetic Analysis AS
| Country | Germany |
| State | N/A |
| City | Oslo |
| Address | Kabelgata 8 |
| ZIP | 0580 |
| Phone | 47 48 32 16 10 |
| Website | https://www.genetic-analysis.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 22 |
Genetic Analysis AS, a science-based diagnostic company, develops diagnostic solutions for human microbiome market. It offers GA-map Dysbiosis Test Lx, a molecular assay for profiling the gut microbiota to identify and characterize dysbiosis for treating patients with Irritable Bowel Syndrome, Inflammatory Bowel Disease, diabetes type 2, gut disorder, lifestyle diseases, and leaky-gut syndrome; GA-map COVID-19 Fecal Test Kit, a qualitative real time standardized PCR test for the detection of the 2019 novel coronavirus RNA in stool samples; GA-map Dysbiosis Test reagent kit, a CE-IVD documented test, which is a software that performs QC on the run file, calculates the dysbiosis index score and abundance table, and converts sample result into reports; and GA-map Covid fecal test reagent kit, a CE-IVD documented test to detect SARS-CoV-2 in fecal samples. The company was founded in 2008 and is headquartered in Oslo, Norway.
Q&A For Genetic Analysis AS Stock
What is a current 8V8.F stock price?
Genetic Analysis AS 8V8.F stock price today per share is 0.04 EUR.
How to purchase Genetic Analysis AS stock?
You can buy 8V8.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Genetic Analysis AS?
The stock symbol or ticker of Genetic Analysis AS is 8V8.F.
Which industry does the Genetic Analysis AS company belong to?
The Genetic Analysis AS industry is Diagnostics & Research.
How many shares does Genetic Analysis AS have in circulation?
The max supply of Genetic Analysis AS shares is 58.21M.
What is Genetic Analysis AS Price to Earnings Ratio (PE Ratio)?
Genetic Analysis AS PE Ratio is now.
What was Genetic Analysis AS earnings per share over the trailing 12 months (TTM)?
Genetic Analysis AS EPS is -0.05 EUR over the trailing 12 months.
Which sector does the Genetic Analysis AS company belong to?
The Genetic Analysis AS sector is Healthcare.